Reduced expression of FAS may cause less cancer cells to undergo apoptosis and at the same time may protect the cells from elimination by antitumor immune response, while increased FASL expression may increase the ability of tumor cells to counterattack the immune system by killing FAS–sensitive lymphocytes, thereby contributing to cancer development (Gratas et al., 1998). Here, FAS is linked to neoplasm.